Non resident directors economic substance risks and how to mitigate them

Content

I have headed COREDO since 2016 and see every day how the regulatory environment around international structures is changing. A non-resident director and economic presence (substance) for companies are two themes that determine the resilience of a business when operating across multiple jurisdictions. Over recent years COREDO’s practice confirms: this is where the interests of tax authorities, banks, auditors and potential investors converge, and the cost of mistakes is rising along with BEPS trends, tightened AML/CTF and bank de-risking.

My goal is to provide clear guidance on how to close the risks of a non-resident director and build economic presence so as to pass bank and tax checks, reduce the likelihood of disputes over a permanent establishment (PE) and ensure transparency for compliance. Below is a concentrated set of methods and solutions that the COREDO team has implemented in the EU, the UK, Singapore, Dubai, Cyprus, Estonia, the Czech Republic and Slovakia. I’ll be frank: there are no easy answers, but you will get a strategic plan and practical steps you can start implementing as soon as tomorrow.

Why substance matters

Illustration for the section 'Why substance matters' in the article 'Non-resident directors — substance risks and how to address them'

The global OECD BEPS agenda and its continuation in the form of Pillar Two, local economic substance regulations (ESR), and expanded PE rules have changed the basic logic of structuring.

If in the past many relied on registration and the address, today what matters is the place of effective management (place of effective management), the actual location of functions and the management team, and documentary evidence. Add CRS: the automatic exchange of financial information, and FATF standards for AML risk assessment: the picture becomes complete.

The banking sector is conducting its own de-risking. Companies with a non-resident director and weak economic presence come under increased scrutiny, face enhanced Due Diligence, requests for substance plans, and the risk of being denied services. Our experience at COREDO has shown that even a strong business model without sufficient evidence of governance and control often loses out to structures with a solid compliance package and a transparent place of management.

Non-resident director: who they are and the risks

Illustration for the section «Non-resident director: who they are and the risks» in the article «Non-resident directors — substance risks and how to address them»

A non-resident director is the head of a company who is not a tax resident of the company’s jurisdiction of incorporation.

This status is legal in itself, but it creates specific risks: ranging from the director’s tax residency and their personal liability under AML/CTF rules to claims that the place of effective management is in another country. In some cases this results in the creation of a permanent establishment (PE) and additional tax reassessments.

Key area: the personal liability of the non-resident director. Regulators increasingly place targeted responsibility on the director for AML breaches/CTF, inaccurate reports, inadequate internal controls and unauthorized payments. Add to this requirements on immigration status and social contributions: in some jurisdictions the director’s regular presence and their involvement in hiring personnel create tax and social obligations that should be addressed in advance.

Company presence: requirements and levels

Illustration for the section «Company presence: requirements and levels» in the article «Non-resident directors — substance risks and how to address them»
Economic substance requirements consist of a combination of factors: a real office, employees on payroll, local directors, regular meetings, and the management of key risks and functions in the jurisdiction. ESR in different countries set minimum criteria for relevant activities (for example, holding, distribution, financing, IP holding), and also define safe harbour rules and exceptions. In Europe and Asia the focus is shifting from “paper” to “functional” substance: it’s not the sign on the door that matters, but where decisions are actually made and operations are carried out.

I often suggest viewing substance as a set of maturity levels. Basic – a registered address and secretarial functions. Intermediate – a physical office, local staff, directors with real powers, local suppliers and invoices. Advanced: own management functions, local accounting and risk-management systems, a developed compliance framework, documentation of commercial decisions and transfer pricing, supporting documents for IP and intercompany agreements.

How to demonstrate a company’s substance

  • Minutes of board meetings (board minutes), agendas, board pack, voting records, evidence of physical or remote attendance.
  • Office lease agreements, photos/layouts of premises, best practices for workstation setup and desk-sharing, utility and communications bills.
  • employment contracts, payroll registers, KPIs for directors and key employees, local job descriptions.
  • Invoices, contracts, business correspondence confirming where transactions were initiated and approved, access logs to corporate systems.
  • On-site accounting, local audit, tax returns and filings, documents on transfer pricing and intercompany agreements.
  • Intellectual property management documents (IP holding), licenses, software rights, R&D activity and budget.
  • Corporate governance policies, AML/CTF policies, compliance reports, results of internal audits and training.

Lack of substance: consequences

Lack of substance and the consequences are obvious: risk of being treated as a PE and additional tax assessments, account freezes, refusal to open bank accounts and increased auditor inquiries.

Issues with tax residency, CFC rules, as well as claims regarding the place of effective management can affect double taxation treaties. The reputational risk should not be underestimated either: investors and partners increasingly check ESR and corporate governance as part of due diligence.

Confirm the substance of an offshore company

Illustration for the section «Confirm the substance of an offshore company» in the article «Non-resident directors — substance risks and how to address them»
The COREDO team implemented a «90-day plan» for clients who need to quickly move from formal registration to a sustainable presence. In the first stage we identify ESR-relevant activities and build a functions matrix: where risks arise, where commercial decisions are made, who signs and who actually controls. Next we provide a physical office, a local accounting and HR structure, configure AML/CTF and corporate policies, set directors’ KPIs and start documentation.

The second stage, digital evidence: we implement tools to record participation in management (electronic minutes, access logs, videoconference recordings), a DMS for storing board packs, SSO and role control. The solution developed at COREDO includes minutes templates, a board cadence regulation, an authority matrix, a risk escalation procedure and an electronic signature policy with timestamps. In the third stage we calculate ROI: CAPEX for the office and equipment, OPEX for payroll and outsourcing, the effect on banking KYC, tax certainty, transaction speed and access to investments.

Director’s presence in the jurisdiction

There are no universal «magic numbers», but COREDO’s practice confirms several rules.

It is important to hold key meetings in the jurisdiction where the company is registered, record the director’s participation, and keep tickets and boarding passes if the meeting is in-person. For remote meetings, collect electronic evidence of participation and geolocation, use corporate communications and domain accounts, and also record that decisions were made and agreed upon in the required country.

Documents for the bank and tax authorities: substance
The bank most often requests: a lease agreement, invoices for office and communications, a payroll register, the presence of local directors/employees, real contracts with clients/suppliers and minutes of meetings. The tax authority focuses on management decisions, minutes, actual profitability, transfer pricing and the availability of resources matching the business profile. Useful for both recipients are: board pack, access logs, business correspondence, local filings and auditor reports.

Remote board of directors meetings
Use platforms with video recording and system logs, store the agenda, materials and voting results in a centralized DMS. Specify the regulations: quorum, roles, timings, the procedure for storing minutes and evidence. Electronic evidence — login logs with IP addresses, timestamp certificates, electronic signature protocols — will strengthen your position during banking and tax audits; at the same time, take into account GDPR and data security policies.

Risks of nominee directors

Illustration for the section «Risks of nominee directors» in the article «Non-resident directors — substance risks and how to address them»
Nominee directors can create serious risks for a company: from legal liability to loss of control and reputational damage. In the following subsections we will examine these risks in detail and suggest practical mechanisms to mitigate them.

How to reduce the risks of nominee directors

A nominee director without real powers: a classic trigger for questions about substance and governance.

Banks and tax authorities view such arrangements as a red flag, especially if the nominee’s compensation is disproportionately low and there is no evidence of participation in management. To reduce risks, ensure actual involvement, a clear scope of authority, AML training/CTF and regular reporting by the director to the board, as well as D&O insurance and documentation of decisions.

Agreement with a nominee director: risks
In the agreement specify: the subject and limits of powers, an SLA for participation in meetings, the right to access information, AML/CTF and confidentiality obligations, and the payment-signing procedure. Add a director indemnity with reasonable limits, a risk escalation process and the director’s right to request an external opinion. Indicate which electronic and physical evidence they are required to retain, as well as KPIs — timeliness of minutes, participation in KYC, quality of compliance reports.

When to appoint a local director?
For regulated businesses — payment, EMI, forex, crypto (VASP), investment licenses — the presence of resident directors is usually mandatory. In the EU with the introduction of MiCA, and also in the UK, Singapore and Dubai, regulators expect fit-and-proper directors, real control and the local presence of an MLRO/Compliance Officer. In such cases appointing a local director is not an option but a requirement for licensing and banking services.

PE and the director’s residency

Place of effective management, where key managerial decisions are made.

If a non-resident director actually manages from their country, the risk increases that the company’s tax residency will be transferred or that a PE will be recognized with taxation of profits. In this area a certificate of tax residency, evidence of meetings held in the company’s “home” territory and a distribution of functions that excludes management from third countries help.

Director migration and tax residency

A director’s prolonged stay in a particular country can affect their tax residency and entail social security contributions.

Bilateral double taxation treaties include “tie-breaker” tests, but in practice it’s the evidence that matters: days of presence, center of vital interests, property ties and place of employment. In practice, COREDO arranges the calendar of meetings and business trips to prevent the “shifting” of the place of management.

Tax claims and risk
PE risk arises when key deal-closing functions are performed in a country, or distribution or marketing is conducted there with the authority to bind the company to obligations. For a non-resident director this means: do not sign or approve key contracts outside the company’s “home” jurisdiction without a well-thought-out matrix of authorities. We prepare intercompany agreements, sales regulations and TP documents to reduce the likelihood of PE being recognized.

Bank compliance: KYC, EDD, de-risking

Banks pay particular attention to structures with a non-resident director: source of funds, business model description, a list of management evidence, UBO register and AML policies become a standard package.

De-risking strengthens filters: lack of substance leads to refusals or account closures, especially for higher-risk sectors — fintech, forex, crypto, cross-border trading. I recommend preparing a “bank dossier” in advance: compliance profile, a functional map, minutes, office photos and payroll.

KYC and de-risking: non-resident directors

The impact is direct: onboarding time increases, request frequency grows, service pricing and limits change.

Enhanced Due Diligence may require an interview with the non-resident director, confirmation of his involvement, checks of migration status and professional reputation. If there is no evidence of management and control, the likelihood of refusal increases manifold.

Bank refusals due to lack of substance

A recent COREDO case: a trading company from Asia planned to open an account in the EU. The non-resident director was managing from a third country, the office was only on paper. The bank refused. We strengthened the presence: an actual lease, local sales staff and financial control, set up board cadence and delivered a package of evidence. The second bank completed onboarding in 5 weeks, limits: no restrictions, requests: in the “green zone”.

Jurisdictions, regulatory changes 24–26

The years 2024–2026 bring a tightening of substance requirements in several regions. In the EU a package against “shell” companies (anti-shell) is being discussed; already many regulators are strengthening tests of actual management and economic activity at the national level. In Asia an updated “foreign-sourced income exemption” regime operates with substance tests in Hong Kong, Singapore is modernizing GAAR and cross-border compliance tools, and the UAE has introduced corporate tax and is clarifying PE and ESR criteria.

Cyprus and Malta are adjusting governance and control practices with a focus on actual directors, internal controls and local functions. Offshore centres continue to update ESR and penalty measures, and banks are updating risk assessment methods and EDD. For businesses this means one thing: the “formal address” standard no longer works; systematic proof of substance will be required.

Compliance for non-resident directors

I recommend a 12-month compliance plan that the COREDO team customizes for a specific profile:

  • Quarter 1: functional map, risk matrix (risk-profile assessment methodologies), ESR tests, governance and AML/CTF procedures, board cadence design.
  • Quarter 2: office and staff, local accounting function, implementation of DMS and e-board, KPIs for directors, launch of evidence storage (logs, minutes, SSO).
  • Quarter 3: transfer pricing, intercompany agreements, MLRO/Compliance, staff training, pilot internal audit and remediation plan.
  • Quarter 4: rehearsal of tax and bank inspections, procedure adjustments, voluntary disclosure if necessary, preparation for investor due diligence.

Metrics for assessing substance adequacy

  • Number and venue of meetings, share of local directors in the quorum.
  • Ratio of payroll and management functions to business scale (payroll-to-revenue/EBIT).
  • Share of local counterparties and expenses using local infrastructure.
  • Response time to compliance requests, completeness of minutes and board pack.
  • Share of decisions confirmed by participation logs and geolocation.
  • Degree of compliance of TP documentation with the functional profile.

Non-resident’s liability under AML/CTF
In many jurisdictions a director bears personal responsibility for the implementation and AML effectiveness/CTF policies. This requires clear role allocation with the MLRO, provision of training, quality control of KYC and reporting of suspicious transactions. I strongly recommend D&O insurance and contractual provisions on director indemnity, balanced with regulatory duties.

What an auditor checks when assessing substance
The auditor assesses not only the numbers but also the processes: where decisions are made, how correctly minutes are prepared, and whether the functional reporting model aligns with TP. Attention is paid to evidence of management and control, as well as ESR compliance. COREDO’s practice confirms: pre-prepared board packs and participation logs reduce up to 70% of auditors’ clarification requests.

Collecting substance evidence and expenses
Use electronic meeting registers, e-signature systems with timestamps, a corporate calendar integrated with DMS and CRM. Store access logs, video conference recordings, version documents and build automated reports on directors’ KPIs. This approach reduces manual work, creates a “compliance trail” and simultaneously lowers OPEX.

Cost and ROI from substance

The cost is provided from two buckets: CAPEX (office, equipment, IT setup) and OPEX (rent, payroll, outsourced compliance, accounting, audit). ROI is composed of reduced PE risks and additional tax assessments, faster bank onboarding, improved service terms and the cost of capital when raising investments. When we assess ROI, we apply a risk-adjusted model: if even a 10–15% probability of a tax dispute converts into large additional assessments, a well-structured substance often pays off within a 12–24 month horizon.

Strategy for scaling substance

When entering new markets, I recommend proceeding in stages. First – “light presence”: a local director/advisors, remote meetings with supporting evidence, pilot sales and local reporting. Then: reinforcement: office, employees, local risk management function, intercompany agreements and TP. At the final stage, consolidation of IP, local R&D or client functions where it is economically and tax-justified.

COREDO case studies in the EU and Asia

  • Fintech payment services provider in the EU: non-resident director, weak office, bank complaints about lack of governance. The COREDO team rebuilt governance: a local managing director, monthly on-site board sessions, payroll for the compliance team, revised AML/CTF policies. Result: successful license renewal and growth in turnover without restrictions.
  • Trading company in Singapore: PE risks in a third country due to a remote director and aggressive cross-border marketing. We implemented an authority matrix, moved the execution of key contracts to Singapore, put intercompany agreements and TP in place. Tax claims were withdrawn, the bank approved an increased limit.
  • Crypto business in Estonia: bank rejection due to lack of substance and risks of a non-resident director. Solution: a real office, a local MLRO, evidence of management and transaction monitoring, enhanced KYC procedure for clients. Within 3 months the company opened accounts in two banks and moved to a MiCA-ready risk management policy.

COREDO Protection for Non-Resident Directors

The solution developed by COREDO encompasses a structure audit, a risk matrix, a functional profile, an ESR assessment and corporate governance design. We tailor processes to the specific jurisdiction: from appointing local directors to preparing agreements with a nominee director with clear SLAs, indemnities and KPIs. The project team includes legal and tax advisors, AML and banking KYC specialists, as well as a manager responsible for automating evidence.

Our experience at COREDO has shown that lasting results come from continuous support. Quarterly reviews of minutes and board packs, updates to AML/CTF policies, rehearsals of banking and tax audits, and preparation for investor due diligence maintain the required level of substance and reduce operational risks. The goal: manageability and predictability, not one-off “cosmetic” fixes.

Checklists and step-by-step instructions

  • For non-resident director:
    • Keep a calendar of meetings and trips; keep tickets and meeting agendas.
    • Sign key decisions in the company’s «home» jurisdiction; record electronic evidence.
    • Complete AML/CTF training, agree on the authority matrix and reporting schedule.
  • For CFO/compliance:
    • Create a DMS: minutes, board pack, logs, contracts, invoices, TP files.
    • Check ESR requirements and adapt payroll, office, and local functions.
    • Update the KYC package for banks, conduct internal audits and PE/CFC tests.
  • For shareholders and the CEO:
    • Determine a presence strategy: from «light» to «full-function» level.
    • Track substance metrics and directors’ KPIs, implement regular reporting.
    • Plan CAPEX/OPEX and calculate ROI taking tax and banking effects into account.

Conclusions

Non-resident director: not a threat in itself, but without a well-thought-out economic presence and evidence of management it becomes a source of systemic risks.

My recommendation is simple: treat substance as an investment in governance and business value, not as a formal checkbox. The COREDO team has carried out dozens of projects with clients in the EU and Asia, and I know that a consistent compliance plan, transparent corporate documentation and real management in the relevant jurisdiction make it possible to confidently pass bank and tax inspections, reduce the cost of capital and scale operations.

If you see your current challenges in this text, from ESR and PE to bank de-risking, then you are on the right track.

Solutions exist here, and they are measurable: from directors’ KPIs and automation of evidence to reworking TP and intercompany agreements. COREDO’s practice confirms: companies that invest in substance in a timely manner grow faster, have fewer disputes and find it easier to attract financing.

LEAVE AN APPLICATION AND GET
A CONSULTATION

    By contacting us you agree to your details being used for the purposes of processing your application in accordance with our Privacy policy.

    COREDO – EU Legal & Compliance Services Expert legal consulting, financial licensing (EMI, PSP, CASP under MiCA), and AML/CFT compliance across the European Union. Headquartered in Prague, we provide seamless regulatory solutions in Germany, Poland, Lithuania, and all 27 EU member states.